Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
The Procter & Gamble Company earnings per share (EPS) for the twelve months ending Mar 03, 2025 was $4.5, a (26.4%) increase year-over-year.
As of Mar 03, 2025, The Procter & Gamble Company's P/E ratio is 37.9x. This is calculated by dividing the current share price of $175.6 by the Earnings per Share (EPS) for the trailing twelve months, which is $4.5. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
The Procter & Gamble Company is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $135.9, compared to a market price of around $175.6. This suggests a potential overvaluation of 22.6%.